Alcohol Use Disorder: An Overview
Written by: Austin Lin, MD Although the opioid epidemic garners national attention, alcohol use remains a major problem. According to the 2017 National Survey on Drug Use and Health, there were approximately 141 million Americans aged 12 or older who…
Diabetes drug could help smokers kick the habit
Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston (UTHealth). To help…
Opioid crisis
Michael Weaver, MD, was interviewed on FOX 26 News this morning about the rise in opioid overdose deaths.
Meth addiction has roared back in Texas. Can new experimental treatment stop it?
A UTHealth Psychiatry clinical trial for methamphetamine use was featured in Sunday’s front-page story in the Houston Chronicle with quotes from Joy Schmitz, Ph.D., Michael Weaver, M.D., and trial participants
UTHealth receives $2.5 million for HIV education and treatment for persons with substance use disorders
HOUSTON – (Oct. 31, 2017) – A $2.5 million federal grant will allow a multidisciplinary team at The University of Texas Health Science Center at Houston (UTHealth) to provide prevention and treatment information about HIV, AIDS and sexually transmitted diseases…
UTHealth researchers receive $2.6 million to study gene-environment interactions in cocaine addiction
HOUSTON – (Oct. 2, 2017) – Studying the effect of environmental stressors on the development of cocaine use is the focus of a $2.6 million award from the National Institutes of Health (NIH) to researchers at McGovern Medical School at…
Heads Receives $50,000 Grant from Robert Wood Johnson Foundation
The Robert Wood Johnson Foundation (RWJF), the nation’s leading philanthropy on health and health care, has awarded Angela M. Heads, Ph.D., Assistant Professor in in the UTHealth McGovern Medical School’s, Department of Psychiatry and Behavioral Sciences a 12-month grant through…
UTHealth a site for first-ever large NIDA trial for methamphetamine use disorder
With the rates of methamphetamine use reaching an all-time high in Texas, McGovern Medical School researchers have launched a clinical trial designed to treat methamphetamine use disorder. The Center for Neurobehavioral Research on Addiction (CNRA) in the Department of Psychiatry…